178 related articles for article (PubMed ID: 30882672)
21. The simultaneous appearance of a nasal natural killer-cell lymphoma and acute myelogenous leukemia.
Van Crombrugge L; De Vos G; Vanclooster C; Lemmerling M; Kerre T
B-ENT; 2012; 8(1):49-52. PubMed ID: 22545391
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of Extranodal NK/T-Cell Lymphoma, Nasal Type, Compared with Nasal Diffuse Large B-cell Lymphoma.
Tanaka H; Mori E; Akutsu T; Saito S; Tei M; Otori N
Clin Med Insights Oncol; 2023; 17():11795549231156692. PubMed ID: 36908718
[TBL] [Abstract][Full Text] [Related]
23. Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.
Yamaguchi M; Suzuki R; Oguchi M
Blood; 2018 Jun; 131(23):2528-2540. PubMed ID: 29602763
[TBL] [Abstract][Full Text] [Related]
24. Esophageal involvement by extranodal natural killer T cell lymphoma, nasal type, mimicking Ebstein Barr viral esophagitis in a tonsillar lymphoma patient undergoing chemoradiation therapy.
Lee SR; Park EK; Won NH; Kim BS
Asia Pac J Clin Oncol; 2010 Sep; 6(3):149-54. PubMed ID: 20887494
[TBL] [Abstract][Full Text] [Related]
25. Extranodal NK/T cell lymphoma, nasal type, with retrobulbar extraconal phlegmon and naso-oral fistula.
Wong DJY; Parry LA; Bloch AE; Agar N
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30852512
[TBL] [Abstract][Full Text] [Related]
26. Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma.
Suzuki R
Semin Hematol; 2014 Jan; 51(1):42-51. PubMed ID: 24468315
[TBL] [Abstract][Full Text] [Related]
27. Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases.
Tababi S; Kharrat S; Sellami M; Mamy J; Zainine R; Beltaief N; Sahtout S; Besbes G
Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Jun; 129(3):141-7. PubMed ID: 22321911
[TBL] [Abstract][Full Text] [Related]
28. Extranodal nasal-type natural killer/T-cell lymphoma masquerading as recalcitrant sinusitis.
Paik YS; Liess BD; Scheidt TD; Ingram EA; Zitsch RP
Head Neck; 2010 Feb; 32(2):268-73. PubMed ID: 19360743
[TBL] [Abstract][Full Text] [Related]
29. Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma.
Peng YY; Xiong YY; Zhang LX; Wang J; Zhang HB; Xiao Q; Guo SL
Turk J Haematol; 2021 Jun; 38(2):126-137. PubMed ID: 33535731
[TBL] [Abstract][Full Text] [Related]
30. Current treatment approaches for NK/T-cell lymphoma.
Yamaguchi M; Miyazaki K
J Clin Exp Hematop; 2017 Dec; 57(3):98-108. PubMed ID: 28679966
[TBL] [Abstract][Full Text] [Related]
31. Extranodal natural killer/T-cell lymphoma, nasal type, of the orbit mimicking recurrent orbital cellulitis.
Kim JW; An JH
J Craniofac Surg; 2014 Mar; 25(2):509-11. PubMed ID: 24621697
[TBL] [Abstract][Full Text] [Related]
32. Extranodal natural killer/T-cell lymphoma presenting as hypopyon panuveitis: a case report.
Sukon N; Tesavibul N; Choopong P; Panyayingyong N; Boonsopon S
BMC Ophthalmol; 2022 Feb; 22(1):46. PubMed ID: 35100995
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type.
Suzuki R; Suzumiya J; Yamaguchi M; Nakamura S; Kameoka J; Kojima H; Abe M; Kinoshita T; Yoshino T; Iwatsuki K; Kagami Y; Tsuzuki T; Kurokawa M; Ito K; Kawa K; Oshimi K;
Ann Oncol; 2010 May; 21(5):1032-40. PubMed ID: 19850638
[TBL] [Abstract][Full Text] [Related]
34. [Airway obstruction due to localized tracheal lesion of extranodal NK/T-cell lymphoma, nasal type].
Takahashi H; Ohkawara H; Shichishima-Nakamura A; Fukatsu M; Sano T; Harada-Shirado K; Kimura S; Togawa R; Tasaki K; Hashimoto Y; Ogawa K; Ikezoe T
Rinsho Ketsueki; 2018; 59(8):1012-1015. PubMed ID: 30185700
[TBL] [Abstract][Full Text] [Related]
35. NK/T Cell Lymphoma: Updates in Therapy.
Suzuki R
Curr Hematol Malig Rep; 2018 Feb; 13(1):7-12. PubMed ID: 29368155
[TBL] [Abstract][Full Text] [Related]
36. Conjunctival extranodal natural killer/T-cell lymphoma, nasal type.
Kiratli H; Uzun S; Yeşilirmak A; Ayhan AS; Soylemezoğlu F
Cornea; 2015 Jun; 34(6):710-2. PubMed ID: 25811726
[TBL] [Abstract][Full Text] [Related]
37. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-9. Extranodal NK/T-cell lymphoma, nasal type (ENKL).
Yamaguchi M; Suzuki R
Int J Hematol; 2019 Apr; 109(4):371-376. PubMed ID: 30820835
[No Abstract] [Full Text] [Related]
38. Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan.
Yamaguchi M; Suzuki R; Oguchi M; Asano N; Amaki J; Akiba T; Maeda T; Itasaka S; Kubota N; Saito Y; Kobayashi Y; Itami J; Ueda K; Miyazaki K; Ii N; Tomita N; Sekiguchi N; Takizawa J; Saito B; Murayama T; Ando T; Wada H; Hyo R; Ejima Y; Hasegawa M; Katayama N
J Clin Oncol; 2017 Jan; 35(1):32-39. PubMed ID: 28034070
[TBL] [Abstract][Full Text] [Related]
39. Primary pulmonary extranodal NK/T-cell lymphoma of nasal type misdiagnosed as pneumonia: A case report and literature review.
Zhang J; Wang M; Yang X; Liu C; He X
Medicine (Baltimore); 2017 Dec; 96(49):e8914. PubMed ID: 29245256
[TBL] [Abstract][Full Text] [Related]
40. Gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy with sandwiched radiotherapy in the treatment of newly diagnosed stage IE/IIE extranodal natural killer/T-cell lymphoma, nasal type.
Tian S; Li R; Wang T; Wang S; Tao R; Hu X; Ding H
Cancer Med; 2019 Jul; 8(7):3349-3358. PubMed ID: 31050212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
